Reply to letter.

Niv Ben-ShabatAviv ShabatAbdulla WatadKhalaf KridinNicola Luigi BragazziDennis McGonagleDoron ComaneshterArnon D CohenHoward Amital

Published in: Arthritis care & research (2021)

We thank Li et al for their commentary on our recently published paper "Mortality in Ankylosing Spondylitis According to Treatment: A Nationwide Retrospective Cohort Study of 5900 Patients from Israel" (1). Their major concern was regarding the findings which demonstrated no excess mortality in ankylosing-spondylitis (AS) patients treated with TNF-inhibitors (TNFi).

Keyphrases

ankylosing spondylitis
rheumatoid arthritis
disease activity
cardiovascular events
cross sectional
risk factors
systemic lupus erythematosus
type diabetes
systematic review